To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients

Study Identifier:
C11-004J
ClinicalTrials.gov Identifier:
NCT01755429
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete

Study Details

Medical Condition
  • Unmapped
Study Drug
    Date
    May 2012 - May 2012
    Phase 1
    Phase 2
    Phase 3
    Phase 4
    N/A
    Patient Requirements
    Sex: Female & Male
    Age: N/A - N/A
    Requirements Information
    Sex
    Female & Male
    Age
    N/A - N/A

    Study Details

    Medical Condition
    • Unmapped
    Study Drug
      Date
      May 2012 - May 2012
      Phase 1
      Phase 2
      Phase 3
      Phase 4
      N/A
      Patient Requirements
      Sex: Female & Male
      Age: N/A - N/A years
      Requirements Information

      Protocol Summary

      This protocol is intended to formally collect data on the treatment of aHUS with eculizumab in Japanese patients.

      Trial Locations

      Location
      Status
      Location
      Shinshu University School of Medicine
      Matsumoto, Japan
      Status
      N/A
      Location
      Tokyo Medical and Dental University
      Tokyo, Japan
      Status
      N/A